Skip to content

Analysis of influencing factors and risk prediction of major cardiovascular adverse events in perimenopausal women

Analysis of influencing factors and risk prediction of major cardiovascular adverse events in perimenopausal women

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065734
Enrollment
Unknown
Registered
2022-11-14
Start date
2022-12-10
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Cardiovascular Adverse Events

Interventions

Gold Standard:Clinical outcome events
Index test:Risk prediction model for major cardiovascular adverse events in perimenopausal women

Sponsors

Binzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. MACE Group: (1) Meet the diagnostic criteria for perimenopause; (2) Major cardiovascular adverse events were diagnosed for the first time; (3) Voluntary participation in the study; (4) No mental illness, consciousness disorder and other conditions, can cooperate with the research investigation. 2. Non-MACE Group: (1) The diagnostic criteria for perimenopause were met and MACE diagnosis was excluded; (2) Voluntary participation in the study; (3) No mental illness, consciousness disorder and other conditions, can cooperate with the research investigation.

Exclusion criteria

Exclusion criteria: 1. History of hormone drug therapy in recent half a year; 2. Pregnant and lactating patients; 3. Patients with menstrual disorders or menopause due to unnatural causes such as premature ovarian failure and hysterectomy; 4. Patients with malignant tumor, autoimmune system disease, hematological system disease, serious organ disease, etc.

Design outcomes

Primary

MeasureTime frame
Major cardiovascular adverse events;

Countries

China

Contacts

Public ContactChen Xiaolin

School of Nursing, Binzhou Medical University

xiaolin750210@sina.com+86 13854380372

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026